Raimonds Dzelme

Raimonds Dzelme has a diverse work experience in the pharmaceutical industry spanning over two decades. Raimonds is currently serving as the Vice President of Marketing at Azurity Pharmaceuticals since 2020. Prior to this, Raimonds was the Founder and Chairman of DAS Therapeutics, where they focused on identifying and developing unique assets for overlooked conditions. Raimonds also worked as the Principal at Asymmetry Group LLC from 2018 to 2020.

Before that, they held leadership roles as the Vice President of Marketing at Collegium Pharmaceutical, Inc. and Insys Therapeutics, Inc. in 2016. Raimonds also served as the Senior Director of Neurology Marketing at Lundbeck from 2009 to 2015.

Earlier in their career, they gained experience in advertising and strategic consulting roles, including positions at Palio Communications, Saatchi & Saatchi Advertising, and TargetRx, Inc. Raimonds started their career as a Marketing Associate at Eli Lilly & Company.

Raimonds Dzelme obtained a Bachelor of Science degree in Business from the University of the Pacific from 1989 to 1993. Raimonds also pursued an MBA at the Thunderbird School of Global Management from 1997 to 1999. Additionally, they attended the Institute for European Studies in 1992, although no specific degree or field of study is mentioned.